Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer. Among known toxicities induced by oxaliplatin, hematological, gastrointestinal and neurological toxicities are common. However, acute pulmonary toxicity associated with oxaliplatin is unusual. One case of interstitial lung disease associated with the FOLFOX protocol is reported here.
CITATION STYLE
Park, S., Jung, J. J., Kim, G. B., Yoon, H. S., Ko, S. H., Ko, J. E., & Lee, Y. S. (2010). [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin]. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi, 55(5), 340–343. https://doi.org/10.4166/kjg.2010.55.5.340
Mendeley helps you to discover research relevant for your work.